Business Context and Reporting Period
Company: Avra Medical Robotics, Inc. (Note: Request metadata listed "SS Innovations International, Inc.", but the filing text identifies the registrant as Avra Medical Robotics, Inc.)
Filing Type: Form 8-K (Current Report)
Date: May 14, 2020
Context: The Company is an emerging growth company reporting under Item 8.01 (Other Events). This filing discloses a delay in submitting its Quarterly Report on Form 10-Q for the quarter ended March 31, 2020.
Key Financial Metrics
The filing text does not provide specific financial values for revenue, profit, cash flow, margins, debt, or liquidity. This document serves solely as a notice of a filing delay and does not contain the financial statements for the period.
Material Changes and Operational Impact
- Filing Delay: The Company elected to rely on conditional relief provided by an SEC Order (issued March 4, 2020, amended March 25, 2020) due to the COVID-19 outbreak.
- Operational Disruptions: The Company closed its offices and required internal staff to work remotely. Similar social distancing measures were implemented by outside accountants and the independent registered public accounting firm.
- Impact on Reporting: These measures slowed the accounting and auditing work required to compile financial statements for the quarter ended March 31, 2020.
- New Filing Deadline: The Company intends to file the delayed Quarterly Report no later than June 29, 2020 (within 45 days of the original due date).
Outlook, Risks, and Management Commentary
Management Commentary: The Company states it cannot accurately predict the effect the COVID-19 outbreak will have on its operations. The outbreak poses risks of quarantines, facility closures, and logistics restrictions.
Risks and Contingencies:
- Economic Downturn: Broader economic effects of the pandemic could decrease spending, adversely affecting business results and financial condition.
- Forward-Looking Statements: The filing includes standard disclaimers that forward-looking statements involve risks and uncertainties, and actual results may differ materially from expectations.
Key Facts for Investor Verification
- Verify the actual filing date of the Form 10-Q for the quarter ended March 31, 2020, to ensure it was submitted by the new deadline of June 29, 2020.
- Review the delayed Form 10-Q for specific financial impacts of the COVID-19 pandemic on revenue and cash flow, as this 8-K contains no such data.
- Confirm the status of the Company's independent registered public accounting firm and whether the remote work measures affected the audit opinion.
- Monitor subsequent filings for updates on facility closures or logistics restrictions mentioned as potential risks.